Crinetics Pharmaceuticals
The Director, Real-World Evidence (RWE) Scientist designs and executes observational studies for Crinetics' atumelnant program, focusing on congenital adrenal hyperplasia and Cushing's disease. This role involves leading external analysts and vendors to produce rigorous real-world evidence using large healthcare databases and primary data collection. The position requires translating evidence priorities into actionable insights for launch and lifecycle management while ensuring compliance with healthcare regulations.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2008
Crinetics is here for endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.
Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.
3 days ago
WINTON GROUP Ltd Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX
1 day ago
Will Crinetics Pharmaceuticals Inc. stock attract more institutional investors - Insider Buying & High Win Rate Trade Alerts
4 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crinetics Pharmaceuticals.
51% above the average for this role
Why Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration
1 week ago
Senior Director, Epidemiology
AstraZeneca
Senior Director, Epidemiology
AstraZeneca
Director, Epidemiology
Gilead Sciences
Director, Global Epidemiology & Real-World Evidence
shionogi
Real World Biostatistician - RWE CMH experience
Syneos Health
RWE (Assoc) Consultant - Sr Consultant, Real World Solutions
lifelancer